Evidence map›Paper›PMID 42382258›Full record

ArticleFrontiers in chemistry2026

Core-shell structured nanomaterials in dual-modal magnetic resonance imaging guided antitumor effect via combined treatment.

Wei Liu, Chengxin Liu, Longhai Jin, Jianqiu Wang, Jiale Tian, Tianqi Zhang, Jianhua Liu, Yinghui Wang, Shuyan Song

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Wei LiuDepartment of Radiology, The Second Hospital of Jilin University, Changchun, China.
Chengxin LiuDepartment of Radiology, The Second Hospital of Jilin University, Changchun, China.
Longhai JinDepartment of Radiology, The Second Hospital of Jilin University, Changchun, China.
Jianqiu WangDepartment of Radiology, The Second Hospital of Jilin University, Changchun, China.
Jiale TianDepartment of Radiology, The Second Hospital of Jilin University, Changchun, China.
Tianqi ZhangDepartment of Radiology, The Second Hospital of Jilin University, Changchun, China.
Jianhua LiuDepartment of Radiology, The Second Hospital of Jilin University, Changchun, China.
Yinghui WangState Key Laboratory of Rare Earth Resource Utilization, Changchun Institute of Applied Chemistry Chinese Academy of Sciences, Changchun, China.
Shuyan SongState Key Laboratory of Rare Earth Resource Utilization, Changchun Institute of Applied Chemistry Chinese Academy of Sciences, Changchun, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Accurate detection and localization of early-stage breast cancer represent the cornerstone for improving cancer cure rates and extending patient survival. However, selecting therapeutic regimens characterized by high efficacy and minimal side effects remains a formidable clinical challenge. Combining these two goals is now feasible with the innovation and progress of nanomaterials. Herein, we designed and synthesized a novel nanomaterial PDA@Fe-BTC@ MnO

Indexed as

breast cancerCDTMRIPTTtheranostic

Identifiers

PMID42382258
PMCPMC13314854

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.